Abramsky, Lenore, and Jean Chapple. 2003. Prenatal Diagnosis: The Human Side. 2nd ed. Cheltenham, U.K.: Nelson Thornes.
Agathokleous, M., P. Chaveeva, L. C. Y. Poon, and Et al. 2013. ‘Meta-Analysis of Second-Trimester Markers for Trisomy 21’. Ultrasound in Obstetrics & Gynecology 41(3):247–61. doi: 10.1002/uog.12364.
Alessandra Cacciatore. 2009. ‘Obstetric Management in Rh Alloimmunizated Pregnancy’. Journal of Prenatal Medicine 3(2).
American Association for Clinical Chemistry. n.d. ‘Clinical Chemistry’.
Anon. 1975. ‘Journal of Medical Ethics’.
Anon. 1987. ‘Baillière’s Clinical Obstetrics and Gynaecology’. 1(3).
Anon. n.d.-a. ‘Journal of Prenatal Medicine’.
Anon. n.d.-b. ‘Nipd_june_2016.Pdf’.
Anon. n.d.-c. ‘PloS One’.
Barrett, A. N., T. C. R. McDonnell, K. C. A. Chan, and L. S. Chitty. 2012. ‘Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia’. Clinical Chemistry 58(6):1026–32. doi: 10.1373/clinchem.2011.178939.
Benn, Peter A. 2009. ‘Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis’. JAMA 301(20). doi: 10.1001/jama.2009.707.
Bianchi, Diana W., Lawrence D. Platt, James D. Goldberg, and Et al. 2012. ‘Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing’. Obstetrics & Gynecology 119(5):890–901.
Celik, E., M. To, L. C. Y. Poon, and Et al. 2008. ‘Cervical Length and Obstetric History Predict Spontaneous Preterm Birth: Development and Validation of a Model to Provide Individualized Risk Assessment’. Ultrasound in Obstetrics and Gynecology 31(5):549–54. doi: 10.1002/uog.5333.
Chitty, Lyn S., C. Ellen van der Schoot, Sinuhe Hahn, and Neil D. Avent. 2008. ‘SAFE—TheSpecial Non-invasiveAdvances inFetal and NeonatalEvaluation Network: Aims and Achievements’. Prenatal Diagnosis 28(2):83–88. doi: 10.1002/pd.1929.
Chudleigh, Patricia, and Basky Thilaganathan. 2004. Obstetric Ultrasound: How, Why and When. 3rd ed. Edinburgh: Elsevier Churchill Livingstone.
Deans, Zuzana, Angus J. Clarke, and Ainsley J. Newson. 2015. ‘For Your Interest? The Ethical Acceptability of Using Non-Invasive Prenatal Testing to Test “Purely for Information”’. Bioethics 29(1):19–25. doi: 10.1111/bioe.12125.
Deprest, Jan, Alessandro Ghidini, Tim Van Mieghem, Diana W. Bianchi, Brigitte Faas, and Lyn S. Chitty. 2016. ‘In Case You Missed It: The Editors Bring You the Most Significant Advances of 2015’. Prenatal Diagnosis 36(1):3–9. doi: 10.1002/pd.4758.
European Society of Human Genetics. n.d. ‘European Journal of Human Genetics: EJHG.’
Gallo, Dahiana Marcela, Leona C. Poon, Ranjit Akolekar, and Et al. 2013. ‘Prediction of Preeclampsia by Uterine Artery Doppler at 20-24 Weeks’ Gestation’. Fetal Diagnosis and Therapy 34(4):241–47. doi: 10.1159/000356171.
Gallo, Dahiana, Leona C. Poon, Mariana Fernandez, and Et al. 2014. ‘Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks’ Gestation’. Fetal Diagnosis and Therapy 36(1):28–37. doi: 10.1159/000360287.
Harrison, Michael R., Mitchell S. Golbus, Roy A. Filly, and Michael R. Harrison. 2001. The Unborn Patient: The Art and Science of Fetal Therapy. 3rd ed. Philadelphia: Saunders.
Hill, Melissa, Angela N. Barrett, Helen White, and Lyn S. Chitty. 2012. ‘Uses of Cell Free Fetal DNA in Maternal Circulation’. Best Practice & Research Clinical Obstetrics & Gynaecology 26(5):639–54. doi: 10.1016/j.bpobgyn.2012.03.004.
International Fetal Medicine and Surgery Society. n.d. ‘Fetal Diagnosis and Therapy’.
International Society for Prenatal Diagnosis. n.d. ‘Prenatal Diagnosis’. Wiley medical publication.
Massachusetts Medical Society. n.d. ‘The New England Journal of Medicine’.
Milunsky, Aubrey, and Jeff M. Milunsky, eds. 2021. Genetic Disorders and the Fetus. Oxford, UK: John Wiley & Sons Ltd.
Nicolaides, Kypros H. 2011. ‘Turning the Pyramid of Prenatal Care’. Fetal Diagnosis and Therapy 29(3):183–96. doi: 10.1159/000324320.
Pandya, Pranav P., Ronald Wapner, Dick Oepkes, and N. J. Sebire, eds. 2020. Fetal Medicine: Basic Science and Clinical Practice. Third edition. [London?]: Elsevier.
Ravitsky, Vardit. 2009. ‘Non-Invasive Prenatal Diagnosis: An Ethical Imperative’. Nature Reviews Genetics 10(10):733–733. doi: 10.1038/nrg2631-c1.
Sadler, T. W. 2015. Langman’s Medical Embryology. Thirteenth edition, International edition. Philadelphia: Wolters Kluwer.
Simpson, Joe Leigh, and Sherman Elias. 1993. Essentials of Prenatal Diagnosis. New York: Churchill Livingstone.
Smith, N. C., A. Pat M. Smith, and N. C. Smith. 2006. Obstetric and Gynaecological Ultrasound Made Easy. 2nd ed. Edinburgh: Elsevier Churchill Livingstone.
Sparks, Andrew B., Eric T. Wang, Craig A. Struble, and Et al. 2012. ‘Selective Analysis of Cell-Free DNA in Maternal Blood for Evaluation of Fetal Trisomy’. Prenatal Diagnosis 32(1):3–9. doi: 10.1002/pd.2922.
Syngelaki, Argyro, Teodora Chelemen, Themistoklis Dagklis, and Et al. 2011. ‘Challenges in the Diagnosis of Fetal Non-Chromosomal Abnormalities at 11-13 Weeks’. Prenatal Diagnosis 31(1):90–102. doi: 10.1002/pd.2642.
Syngelaki, Argyro, Eugene Pergament, Tessa Homfray, and Et al. 2014. ‘Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities’. Fetal Diagnosis and Therapy 35(3):174–84. doi: 10.1159/000358388.
Wald, Nicholas J., and Jonathan P. Bestwick. 2015. ‘Performance of Antenatal Reflex DNA Screening for Down’s Syndrome’. Journal of Medical Screening 22(4):168–74. doi: 10.1177/0969141315581005.
Wright, C. F., and H. Burton. 2008. ‘The Use of Cell-Free Fetal Nucleic Acids in Maternal Blood for Non-Invasive Prenatal Diagnosis’. Human Reproduction Update 15(1):139–51. doi: 10.1093/humupd/dmn047.
